Rhiannon Mellor
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.
Journal: Prostate cancer and prostatic diseases
Published: January 03, 2026
Much ado about mentorship: a qualitative analysis of participant feedback from the inaugural Australian National Oncology Mentorship Programme.
Journal: Internal medicine journal
Published: February 28, 2025
Immunotherapy in metastatic prostate cancer.
Journal: Therapeutic advances in medical oncology
Published: February 17, 2025
Characterising the effect of circulating sphingolipids on metastatic prostate cancer cells.
Journal: EBioMedicine
Published: January 22, 2025
Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapy.
Journal: Therapeutic advances in medical oncology
Published: September 09, 2024
Response to Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy".
Journal: The Journal of clinical endocrinology and metabolism
Published: July 03, 2024
Evaluating Systemic Burnout in Medical Oncology Through a National Oncology Mentorship Program.
Journal: JCO oncology practice
Published: January 30, 2024
Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: December 29, 2023
Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 31, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026